Keith Regnante - Net Worth and Insider Trading
Keith Regnante Net Worth
The estimated net worth of Keith Regnante is at least $91,449 dollars as of 2024-05-02. Keith Regnante is the CFO of WAVE Life Sciences Ltd and owns about 15,686 shares of WAVE Life Sciences Ltd (WVE) stock worth over $91,449. Keith Regnante is also the CFO of Keros Therapeutics Inc and owns about 0 shares of Keros Therapeutics Inc (KROS) stock worth over $0. Details can be seen in Keith Regnante's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith Regnante has not made any transactions after 2023-11-04 and currently still holds the listed stock(s).
Transaction Summary of Keith Regnante
Keith Regnante Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Regnante owns 2 companies in total, including Keros Therapeutics Inc (KROS) , and WAVE Life Sciences Ltd (WVE) .
Click here to see the complete history of Keith Regnante’s form 4 insider trades.
Insider Ownership Summary of Keith Regnante
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2023-11-04 | Chief Financial Officer |
| WVE | WAVE Life Sciences Ltd | 2019-02-19 | Chief Financial Officer |
Keith Regnante Latest Holdings Summary
Keith Regnante currently owns a total of 2 stocks. Among these stocks, Keith Regnante owns 15,686 shares of WAVE Life Sciences Ltd (WVE) as of February 19, 2019, with a value of $91,449 and a weighting of 100%. Keith Regnante also owns 0 shares of Keros Therapeutics Inc (KROS) as of November 4, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Keith Regnante
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2019-02-19 | 15,686 | 5.83 | 91,449 |
| KROS | Keros Therapeutics Inc | 2023-11-04 | 0 | 57.55 | 0 |
Holding Weightings of Keith Regnante
Keith Regnante Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith Regnante has made a total of 0 transactions in WAVE Life Sciences Ltd (WVE) over the past 5 years. The most-recent trade in WAVE Life Sciences Ltd is the sale of 1,298 shares on February 19, 2019, which brought Keith Regnante around $47,818.
According to the SEC Form 4 filings, Keith Regnante has made a total of 2 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 40,000 shares on November 4, 2023, which brought Keith Regnante around $2 Million.
Insider Trading History of Keith Regnante
- 1
Keith Regnante Trading Performance
Keith Regnante Ownership Network
Keith Regnante Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Keith Regnante is the Chief Financial Officer of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Scientific Officer Jennifer Lachey , Chief Operating Officer Christopher Rovaldi , and Chief Medical Officer Simon Peter Cooper .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Keith Regnante made 2 insider transaction in Keros Therapeutics Inc (KROS) with a net sale of 80,000.
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 80,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,000 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Keith Regnante Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Regnante. You might contact Keith Regnante via mailing address: 733 Concord Avenue, Cambridge Ma 02138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
